LAUSANNE, Switzerland--(BUSINESS WIRE)--NewBiologix SA, a technology innovation company focused on addressing gene and cell therapy manufacturing gaps, announced today the launch of NBX-HEK293, the ...
Demand is on the rise for recombinant adeno‐associated viruses (rAAVs) used in the development of gene therapies. Late in October, Amy Shen, PhD, a principal scientist in the department of cell ...
Researchers recently enhanced the titer of a cell line still in development to produce adenovirus viral vectors by 7.5-fold, and without the risk of also producing replication-competent adenoviruses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback